Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-28

Clinical Trial Update: Zinc Sulphate in Treatment Fibrosis in HBV Patient Receiving Antiviral Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating zinc sulfate for treating liver fibrosis in patients with hepatitis B who are receiving antiviral therapy; the study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zinc sulfate (Zinc sulfate)

Snippet

Sponsor: Tanta University | Conditions: Liver Fibroses, HBV (Hepatitis B Virus) | Phase 2 | Status: NOT_YET_RECRUITING